Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$85.31 n/a | n/a%
07/21/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 6.49B 5.51B 4.84B 3.63B
Cost of Sales 229.10M 210.18M 352.23M 250.66M
Gross Operating Profit 6.26B 5.30B 4.49B 3.38B
Selling, General, and Administrative Expenses 1.68B 1.37B 1.23B 950.63M
Research & Development 2.23B 1.72B 1.60B 1.13B
Operating Income before D & A (EBITDA) 2.35B 2.20B 1.66B 1.30B
Depreciation & Amortization 374.10M 283.45M 362.85M 259.09M
Interest Income 0.00 15.26M 25.86M 44.76M
Other Income - Net -223.00M -17.01M -3.55M -11.08M
Special Income / Charges 171.10M -168.95M 284.69M 0.00
Total Income Before Interest Expenses (EBIT) 1.76B 1.74B 1.46B 1.03B
Interest Expense 91.60M 63.20M 42.74M 12.63M
Pre-Tax Income 1.67B 1.68B 1.42B 1.01B
Income Taxes 215.50M 225.31M 102.07M 132.42M
Minority Interest 0.00 0.00 -694.00K -320.00K
Net Income From Continuing Operations 1.45B 1.46B 1.32B 880.19M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.45B 1.46B 1.32B 880.19M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.45B 1.46B 1.32B 880.51M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.45B 1.63B 1.18B 927.42M
Preferred Dividends
Net Income Available To Common 1.45B 1.46B 1.32B 880.19M
Basic EPS from Continuing Ops. 1.75 1.69 1.45 0.95
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.75 1.69 1.45 0.95
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.75 1.69 1.45 0.95
Basic Normalized Net Income/Share 1.75 1.89 1.29 1.00
EPS fr Continuing Ops. 1.68 1.65 1.42 0.94
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.68 1.65 1.42 0.94
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.69 1.65 1.43 0.94
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.68 1.84 1.27 0.99
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter